newsfilter
← Latest News
GlobeNewswire·

Jounce Therapeutics to Present at Upcoming Investor Conferences in January

CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that company manag